Humana/$HUM

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Humana

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Ticker

$HUM
Sector

Primary listing

NYSE

Employees

65,680

Humana Metrics

BasicAdvanced
$34B
21.76
$13.04
0.44
$3.54
1.25%

What the Analysts think about Humana

Analyst ratings (Buy, Hold, Sell) for Humana stock.

Bulls say / Bears say

On July 30, 2025, Humana raised its full-year 2025 adjusted EPS guidance to approximately $17.00 and revenue guidance to at least $128 billion following stronger-than-expected Q2 results, reflecting confidence in its cost control and margin outlook (Reuters ).
In Q1 2025, Humana reported an adjusted EPS of $11.58, beating analysts’ estimates and achieving a medical cost ratio of 87.4%, underscoring effective cost management amid inflationary pressures (Reuters ).
Growth in Humana’s CenterWell primary care segment was cited by Reuters as a key driver of its improved first-half performance, helping to diversify revenue streams and strengthen its value-based care capabilities (Reuters ).
Humana was ordered by a federal court to pay over $32 million in legal fees to whistleblower attorneys under the False Claims Act, highlighting costly litigation risks and potential reputational damage (Reuters ).
A Texas federal judge dismissed Humana’s lawsuit challenging CMS’s lower star ratings for its Medicare Advantage plans, risking reduced quality bonus payments in 2026 and pressuring future profitability (Reuters ).
Despite strong financial results, Humana still anticipates a decline in individual Medicare Advantage memberships of up to 500,000 in 2025, indicating continued contraction in its core insurance business that may pressure revenue growth (Reuters ).
Data summarised monthly by Lightyear AI. Last updated on 30 Sept 2025.

Humana Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Humana Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $HUM

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

FAQs